Category Archives: plasma glucose

Lorcaserin approved by FDA

Posted on June 28, 2012 by pharminpt

Yesterday, the U.S. Food and Drug Administration approved the weight loss drug lorcaserin (Belviq®, Arena Pharmaceuticals). This is the first approval for an obesity treatment since orlistat (Xenical®) in 1999. The effect on weight loss is modest (3-5%) and the … Continue reading →

Posted in plasma glucose, weight loss | Tagged , , , | Leave a comment

A new drug to lower blood glucose and treat type 2 diabetes

Posted on May 12, 2011 by pharminpt

Last Monday, May 2, the FDA approved a new medication for type 2 diabetes. It’s pretty safe to argue that this is a common co-morbidity among patients in rehabilitation. And as far as medications that are important in physical therapy … Continue reading →

Posted in plasma glucose | Tagged , , | Leave a comment